EU active substance registration
Xeolas Pharmaceuticals Limited
EU active substance registration Annual Update 2024 ASR12053/00001 (AUR24/013) · Ireland
Key facts
| Registration number | Annual Update 2024 ASR12053/00001 (AUR24/013) |
|---|---|
| EudraGMDP reference | 48771 |
| Registration holder | Xeolas Pharmaceuticals Limited |
| Registered site | Xeolas Pharmaceuticals Limited |
| Site address | Hamilton R&D Building, DCU, Dublin 9, - |
| Country | Ireland |
| Competent authority | IE_HPRA |
| National site reference | 53621 |
| OMS location ID | LOC-100002764 |
| OMS organisation ID | ORG-100004501 |
| EudraGMDP record | eudragmdp.ema.europa.eu |
At a glance
- None Third-country API manufacturing sites
- 1–9 EudraGMDP certificates and reports for this site
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About EU active substance (API) registrations
Companies in the EEA that manufacture, import or distribute active substances for human medicines must register with their national competent authority. EudraGMDP publishes each registration and the third-country sites that supply the substances.